Aldo Peixoto, MD, FASN

Dr. Peixoto is Professor Emeritus of Medicine in the Section of Nephrology at the Yale School of Medicine. He was also Vice Chair for Quality & Safety (Department of Internal Medicine) and Clinical Chief of the Section of Nephrology until May 2025. After 27 years on the faculty, he left academia in 2025 to pursue a career in drug development and he is currently Medical Director at Regeneron Pharmaceuticals, Inc.

He received his medical degree from the Federal University of Santa Catarina (Brazil) in 1992. He was a medical resident and chief medical resident at the University of Connecticut Health Center from 1992-96 and later completed a nephrology fellowship at Yale University, which he joined as a full-time faculty member in 1998. He is certified in both Nephrology (ABIM) and Clinical Hypertension (ASH).

As a clinician, he is primarily interested in resistant and secondary forms of hypertension, cardiovascular autonomic disorders. He is a founding member of the Hypertension Program at the YNHH Heart and Vascular Center.

He had a longstanding teaching presence in the school and the department, having received several teaching awards from the medical school, the Internal Medicine residency training program, and the CT Chapter of the American College of Physicians. His awards include the Asghar Rastegar Award in 2000 and 2008, the Bohmfalk Teaching Prize in the Basic Sciences in 2008, the Francis G. Blake Award in 2010, and the George Thornton Award in 2017. He mentored more than 30 medical students, residents and renal fellows in their research activities between 2002 and 2025.

As a researcher, his work has focused on hypertension in kidney disease and strategies for the evaluation and management of hypertension. His work has included practice patterns and outcomes of acute severe hypertension in hospitalized patients, ambulatory BP monitoring in ESRD, hemodynamic phenotyping in hypertension, arterial mechanics in hypertension and kidney disease, sodium load in hypertension in ESRD, and a role as site PI in multiple industry-sponsored studies in CKD, hypertension and neurogenic orthostatic hypotension.

He has been a member of the editorial boards of several nephrology and hypertension journals (American Journal of Nephrology, CJASN, Kidney International, Blood Pressure Monitoring), and was Associate Editor of Blood Pressure Monitoring (2007-2020) and Hypertension NephSAP (2010-2016).